Vexienne

01 /

Zusammenfassung

Überblick

Vexienne is a science-based, premium brand platform launched by Swedish biotech Coegin Pharma AB in April 2026 as an own-brand distribution model for its proprietary Follicopeptide peptide portfolio, targeting hair thinning.

02 /

Zeitleiste

Geschichte

2021

Coegin Pharma merged with Swedish biotech Follicum, source of the Follicopeptide technology (formerly FOL-005)↗

2024

Follicopeptide received INCI approval (ingredient name sh-Oligopeptide-128 SP), May 2024↗

2026

VEXIENNE brand launched as Coegin Pharma's own-brand distribution model for the Follicopeptide portfolio (April 2026)↗

2026

Distribution agreement with LYKO for first VEXIENNE product (Hair Active X); commercial launch expected July 2026↗

03 /

Sortiment

Signaturprodukte

Hair Active X (Follicopeptide Gel Serum)

This is the leave-on gel serum we built for hair that has started to look thinner.↗

Hair Optimizer (scalp serum)

Initial launches include: Follicopeptide® Gel Serum (marketed as Hair Active X™) [and] Scalp serum (marketed as Hair Optimizer™)↗

04 /

Formulierung & Philosophie

Inhaltsstoffe & Philosophie

Vexienne positions itself as a science-based, premium hair-care brand built on Coegin Pharma's patented Follicopeptide technology, framed around the idea that hair thinning can be addressed rather than accepted, and presented as an ongoing routine rather than a quick fix.

Follicopeptide (osteopontin-derived peptide; INCI sh-Oligopeptide-128 SP)

05 /

Konzern